- Home
- VEEE vs INDP Comparison
VEEE vs INDP Comparison
Compare VEEE & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- INDP
- Stock Information
- Founded
- VEEE 1994
- INDP 2000
- Country
- VEEE United States
- INDP United States
- Employees
- VEEE N/A
- INDP N/A
- Industry
- VEEE Marine Transportation
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- VEEE Industrials
- INDP Health Care
- Exchange
- VEEE Nasdaq
- INDP Nasdaq
- Market Cap
- VEEE 6.4M
- INDP 6.0M
- IPO Year
- VEEE 2021
- INDP N/A
- Fundamental
- Price
- VEEE $2.31
- INDP $12.33
- Analyst Decision
- VEEE
- INDP Strong Buy
- Analyst Count
- VEEE 0
- INDP 2
- Target Price
- VEEE N/A
- INDP $238.00
- AVG Volume (30 Days)
- VEEE 53.5K
- INDP 698.8K
- Earning Date
- VEEE 08-13-2025
- INDP 08-11-2025
- Dividend Yield
- VEEE N/A
- INDP N/A
- EPS Growth
- VEEE N/A
- INDP N/A
- EPS
- VEEE N/A
- INDP N/A
- Revenue
- VEEE $12,724,465.00
- INDP N/A
- Revenue This Year
- VEEE N/A
- INDP N/A
- Revenue Next Year
- VEEE N/A
- INDP N/A
- P/E Ratio
- VEEE N/A
- INDP N/A
- Revenue Growth
- VEEE N/A
- INDP N/A
- 52 Week Low
- VEEE $2.05
- INDP $7.56
- 52 Week High
- VEEE $9.30
- INDP $66.64
- Technical
- Relative Strength Index (RSI)
- VEEE 50.70
- INDP 54.68
- Support Level
- VEEE $2.14
- INDP $11.87
- Resistance Level
- VEEE $2.40
- INDP $13.40
- Average True Range (ATR)
- VEEE 0.08
- INDP 1.50
- MACD
- VEEE 0.03
- INDP 0.18
- Stochastic Oscillator
- VEEE 67.85
- INDP 76.44
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.